Ask the Expert: Optimal Treatment for ER+, HER2− Early-Stage Breast Cancer in Males

2012 Jan 30, Clifford Hudis, MD

"Ask the Expert” features answers by our experts to your clinical questions. Question: What is the current hormonal therapy recommendation for male breast cancer patients who are ER+, PR+, HER2−, and stage I with no lymph node involvement?Answer: This is an adjuvant therapy question, and the short answer is that we typically treat men in the same way we treat postmenopausal women, but we lean towards tamoxifen, where there is a longer track record in terms of experience.

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Seminal Articles

The definitive list of must-read articles for practicing oncologists

Editors' Choice

Everolimus Plus Tamoxifen Improves Survival in Metastatic Breast Cancer

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration